FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Washington, United States

Biotech startups in Washington, United States

Updated 16 Nov 2026

Reset
Biotech startups in Washington, United States
One-time CSV
  • 123 funded companies, 99 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~washington-united-states.csv123 rows × 18 columns
CompanyCityLast roundAmountDate
Avalyn PharmaSeattleSeries D$100.0M2025-07-22
InduProSeattleSeries B$77.0M2026-08-12
Talus BioSeattleSeed$11.2M2026-09-21
Parse BiosciencesSeattleSeries C$50.0M2023-12-14
Umoja BiopharmaSeattleSeries C$100.0M2025-01-14
Curi BioSeattleSeries B$10.0M2025-12-02
ZipBioSeattleSeed$4.0M2024-09-05
ProfoundBioSeattleSeries B$112.0M2024-02-13

8 rows of the CSV in 5 of its 18 columns.

123
Startups
$5.4B
Total raised
15
Funded in the last 12 months
$317.2M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

11 of 123
11 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Talus Bio Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. Artificial intelligence Seattle Seed $11.2M 2026-09-21 $27.8M Y Combinator, Pioneer Fund, National Science Foundation +2 11 to 50 2020
InduPro InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. Biotech Seattle Series B $77.0M 2026-08-12 $162.0M Euclidean Capital, The Column Group, Vida Ventures +1 51 to 100 2022
Curi Bio Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. Artificial intelligence Seattle Series B $10.0M 2025-12-02 $30.4M National Institutes of Health, Dynamk Capital 11 to 50 2015
Lumen Bioscience Lumen Bioscience discovers, develops, and manufactures biologic drugs and vaccine candidates. Biotech Seattle Series C $30.0M 2025-10-08 $97.0M US Department of Energy, WestRiver Group 101 to 250 2017
LiveGrow Bio LiveGrow Bio is a biotechnology company that manufactures low-cost microbial products with long room-temperature shelf life. Biotech Richland Pre-seed $150K 2025-10-06 $512K MassChallenge Switzerland, Fuse Fund 1 to 10 2019
Avalyn Pharma Avalyn Pharma develops therapies for idiopathic pulmonary fibrosis and other respiratory diseases. Biotech Seattle Series D $100.0M 2025-07-22 $372.5M Eight Roads Ventures, F-Prime, Wellington Management +2 11 to 50 2011
Umoja Biopharma Umoja Biopharma develops immunotherapies intended to treat cancer by engineering the body's own immune cells. Biotech Seattle Series C $100.0M 2025-01-14 $363.0M SoftBank Vision Fund, Temasek, Cormorant Asset Management +2 101 to 250 2019
ZipBio ZipBio develops gene therapies using machine learning, protein engineering, and molecular materials. Biotech Seattle Seed $4.0M 2024-09-05 $4.0M NFX, MoreVC 1 to 10 2022
Parse Biosciences Parse Biosciences develops single-cell sequencing kits for researchers. Biotech Seattle Series C $50.0M 2023-12-14 $100.0M National Science Foundation, Marshall Wace, Horizon Technology Finance +2 101 to 250 2018
Ryp Labs Ryp Labs develops and commercializes technologies that reduce food waste. Biotech Bothell Series A $8.1M 2023-11-22 $19.2M National Science Foundation, BCP Ventures, King Philanthropies 11 to 50 2017
Genemod Genemod provides a unified platform for life scientists to collaborate and manage lab operations. Biotech Seattle Seed $4.5M 2023-05-01 $8.2M Unpopular Ventures, Canaan Partners, Amino Capital +2 11 to 50 2018

Table 1. Biotech startups in Washington, United States: the 11 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 123.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 InduPro InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. Biotech Seattle Series B $77.0M 2026-08-12 $162.0M Euclidean Capital, The Column Group, Vida Ventures +1 51 to 100 2022
2 Talus Bio Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. Artificial intelligence Seattle Seed $11.2M 2026-09-21 $27.8M Y Combinator, Pioneer Fund, National Science Foundation +2 11 to 50 2020
3 Curi Bio Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. Artificial intelligence Seattle Series B $10.0M 2025-12-02 $30.4M National Institutes of Health, Dynamk Capital 11 to 50 2015

Table 2. Biotech startups in Washington, United States: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 National Science Foundation Entrepreneurship program Alexandria, United States 3 2% 1 Talus Bio
2 Alexandria Venture Investments Venture capital firm Pasadena, United States 3 2%
3 Madrona Venture capital firm Seattle, United States 3 2%
4 National Institutes of Health Entrepreneurship program Bethesda, United States 2 2% 2 Talus Bio, Curi Bio
5 RA Capital Management Startup incubator Boston, United States 2 2%
6 OrbiMed Private equity firm New York, United States 2 2%
7 ARCH Venture Partners Venture capital firm Chicago, United States 2 2%
8 Keiretsu Capital Venture capital firm Seattle, United States 2 2%
9 Wellington Management Private equity firm Boston, United States 1 1%
10 Eight Roads Ventures Venture capital firm London, United Kingdom 1 1%
11 F-Prime Venture capital firm Cambridge, United States 1 1%
12 Perceptive Advisors Hedge fund New York, United States 1 1%
13 Andera Partners Private equity firm Paris, France 1 1%
14 Euclidean Capital Family office New York, United States 1 1% 1 InduPro
15 MRL Ventures Fund Corporate venture arm Cambridge, United States 1 1% 1 InduPro

Table 3. Biotech startups in Washington, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 98 80% $4.9B
Software 21 17% $245.1M
Artificial intelligence 15 12% $137.5M
Hardware 6 5% $54.3M
Commerce 2 2% $4.4M
Education 1 1% $440K
Fintech 1 1% $440K

Table 4. Biotech startups in Washington, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 11 9% $190K
Seed 37 30% $1.0M
Series A 30 24% $15.0M
Series B 28 23% $20.0M
Series C 12 10% $30.0M
Series D+ 5 4% $14.0M

Table 5. Biotech startups in Washington, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Seattle 86 70%
Kirkland 7 6%
Bellevue 7 6%
Issaquah 4 3%
Bothell 4 3%
Redmond 2 2%
Pullman 2 2%
Shoreline 2 2%
Friday Harbor 1 1%
Port Orchard 1 1%
Fife 1 1%
Spokane 1 1%

Table 6. Biotech startups in Washington, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 7% $4.2M
September 2026 5 33% $128.9M
August 2026 2 13% $112.0M
June 2026 1 7% $46.0M
May 2026 1 7% $1.0M
April 2026 1 7% $850K
December 2025 4 27% $24.2M

Table 7. Biotech startups in Washington, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 11 9% $293.0M
2025 18 15% $651.2M
2024 7 6% $285.6M
2023 12 10% $187.4M
2022 11 9% $251.3M
2021 11 9% $303.9M

Table 8. Biotech startups in Washington, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 11 9%
2020 to 2022 19 16%
2015 to 2019 43 36%
2010 to 2014 23 19%
Before 2010 24 20%

Table 9. Biotech startups in Washington, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 53 44%
11 to 50 51 42%
51 to 100 8 7%
101 to 250 5 4%
251 to 500 2 2%
501 to 1,000 1 1%

Table 10. Biotech startups in Washington, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Washington, United States are on the list?
123, in the file dated 16 November 2026. 15 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 123 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Washington, United States: 123 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Washington, United States by funding stage

Other sectors in Washington

Biotech startups elsewhere

Cite: FundingWatcher, 123 funded biotech companies in Washington, United States, 16 November 2026. https://fundingwatcher.com/startups/biotech/washington-united-states/